Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med. 2009;361(21):2066–78.
Google Scholar
Le Berre C, Ananthakrishnan AN, Danese S, Singh S, Peyrin-Biroulet L. Ulcerative colitis and crohn’s disease have similar burden and goals for treatment. Clin Gastroenterol Hepatology: Official Clin Pract J Am Gastroenterological Association. 2020;18(1):14–23.
Kaur M, Dalal RL, Shaffer S, Schwartz DA, Rubin DT. Inpatient management of inflammatory bowel Disease-Related complications. Clinical gastroenterology and hepatology: the official clinical practice. J Am Gastroenterological Association. 2020;18(6):1346–55.
Zhao M, Gönczi L, Lakatos PL, Burisch J. The burden of inflammatory bowel disease in Europe in 2020. J Crohn’s Colitis. 2021;15(9):1573–87.
Sahnan K, Adegbola SO, Tozer PJ, Watfah J, Phillips RK. Perianal abscess. BMJ (Clinical Res Ed. 2017;356:j475.
Adamo K, Sandblom G, Brännström F, Strigård K. Prevalence and recurrence rate of perianal abscess–a population-based study, Sweden 1997–2009. Int J Colorectal Dis. 2016;31(3):669–73.
Danese S, Fiorino G, Mary JY, Lakatos PL, D’Haens G, Moja L, D’Hoore A, Panes J, Reinisch W, Sandborn WJ, et al. Development of red flags index for early referral of adults with symptoms and signs suggestive of crohn’s disease: an IOIBD initiative. J Crohn’s Colitis. 2015;9(8):601–6.
Chhaya V, Saxena S, Cecil E, Subramanian V, Curcin V, Majeed A, Pollok RC. Emerging trends and risk factors for perianal surgery in Crohn’s disease: a 20-year national population-based cohort study. Eur J Gastroenterol Hepatol. 2016;28(8):890–5.
Zabana Y, Van Domselaar M, Garcia-Planella E, Mañosa M, San Román AL, Gordillo J, Cabré E, Domènech E. Perianal disease in patients with ulcerative colitis: A case-control study. J Crohn’s Colitis. 2011;5(4):338–41.
Tarrant KM, Barclay ML, Frampton CM, Gearry RB. Perianal disease predicts changes in Crohn’s disease phenotype-results of a population-based study of inflammatory bowel disease phenotype. Am J Gastroenterol. 2008;103(12):3082–93.
Peyrin-Biroulet L, Oussalah A, Williet N, Pillot C, Bresler L, Bigard MA. Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed crohn’s disease. Gut. 2011;60(7):930–6.
Google Scholar
Smith GD, Ebrahim S. Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32(1):1–22.
Skrivankova VW, Richmond RC, Woolf BAR, Davies NM, Swanson SA, VanderWeele TJ, Timpson NJ, Higgins JPT, Dimou N, Langenberg C, et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomisation (STROBE-MR): explanation and elaboration. BMJ (Clinical Res ed). 2021;375:n2233.
Liu JZ, van Sommeren S, Huang H, Ng SC, Alberts R, Takahashi A, Ripke S, Lee JC, Jostins L, Shah T, et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet. 2015;47(9):979–86.
Google Scholar
Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, Hayee B, Lomer MCE, Parkes GC, Selinger C, et al. British society of gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68(Suppl 3):s1–106.
de Lange KM, Moutsianas L, Lee JC, Lamb CA, Luo Y, Kennedy NA, Jostins L, Rice DL, Gutierrez-Achury J, Ji SG, et al. Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease. Nat Genet. 2017;49(2):256–61.
Kurki MI, Karjalainen J, Palta P, Sipilä TP, Kristiansson K, Donner KM, Reeve MP, Laivuori H, Aavikko M, Kaunisto MA, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613(7944):508–18.
Google Scholar
Davies NM, Holmes MV, Smith Davey G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;362(Clinical Res Ed): k601.
Burgess S, Thompson SG. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011;40(3):755–64.
Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304–14.
Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512–25.
Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37(7):658–65.
Sanderson E. Multivariable Mendelian randomization and mediation. Cold Spring Harb Perspect Med. 2021. https://doi.org/10.1101/cshperspect.a038984.
Torres J, Bonovas S, Doherty G, Kucharzik T, Gisbert JP, Raine T, Adamina M, Armuzzi A, Bachmann O, Bager P, et al. ECCO guidelines on therapeutics in crohn’s disease: medical treatment. J Crohn’s Colitis. 2020;14(1):4–22.
Kucharzik T, Tielbeek J, Carter D, Taylor SA, Tolan D, Wilkens R, Bryant RV, Hoeffel C, De Kock I, Maaser C, et al. ECCO-ESGAR topical review on optimizing reporting for Cross-Sectional imaging in inflammatory bowel disease. J Crohn’s Colitis. 2022;16(4):523–43.
Devi J, Ballard DH, Aswani-Omprakash T, Parian AM, Deepak P. Perianal fistulizing Crohn’s disease: current perspectives on diagnosis, monitoring and management with a focus on emerging therapies. Indian J Gastroenterology: Official J Indian Soc Gastroenterol. 2024;43(1):48–63.
Bedi H, Telford J, Penner R, Atkinson K, Karim Z, Wiesinger H, Fu N, Rioux K, Schaeffer D. BS MB: inflammatory bowel disease uncovered in fecal immunochemical test positive patients in a Canadian provincial colon cancer screening program. Sci Rep. 2024;14(1):22967.
Google Scholar
Feroz SH, Ahmed A, Muralidharan A, Thirunavukarasu P. Comparison of the efficacy of the various treatment modalities in the management of perianal Crohn’s fistula: a review. Cureus. 2020;12(12):e11882.
Agrawal M, Spencer EA, Colombel JF, Ungaro RC. Approach to the management of recently diagnosed inflammatory bowel disease patients: a user’s guide for adult and pediatric gastroenterologists. Gastroenterology. 2021;161(1):47–65.
Scharl M, Rogler G. Pathophysiology of fistula formation in crohn’s disease. World J Gastrointest Pathophysiology. 2014;5(3):205–12.
Schwartz DA, Loftus EV Jr., Tremaine WJ, Panaccione R, Harmsen WS, Zinsmeister AR, Sandborn WJ. The natural history of fistulizing crohn’s disease in olmsted County. Minn Gastroenterol. 2002;122(4):875–80.
Kotze PG, Shen B, Lightner A, Yamamoto T, Spinelli A, Ghosh S, Panaccione R. Modern management of perianal fistulas in Crohn’s disease: future directions. Gut. 2018;67(6):1181–94.
Google Scholar
Song EM, Lee HS, Kim YJ, Oh EH, Ham NS, Kim J, Hwang SW, Park SH, Yang DH, Ye BD, et al. Incidence and clinical impact of perianal disease in patients with ulcerative colitis: a nationwide population-based study. J Gastroenterol Hepatol. 2019;34(6):1011–7.
Zimmerman DD. The impact of smoking on perianal disease. Dis Colon Rectum. 2011;54(6):658–9.
Abcarian H. Anorectal infection: abscess-fistula. Clin Colon Rectal Surg. 2011;24(1):14–21.
Thomas T, Chandan JS, Harvey PR, Bhala N, Ghosh S, Nirantharakumar K, Trudgill NJ. The risk of inflammatory bowel disease in subjects presenting with perianal abscess: findings from the THIN database. J Crohn’s Colitis. 2019;13(5):600–6.
Yamamoto T, Nakase H, Watanabe K, Shinzaki S, Takatsu N, Fujii T, Okamoto R, Matsuoka K, Yamada A, Kunisaki R, et al. Diagnosis and clinical features of perianal lesions in newly diagnosed crohn’s disease: subgroup analysis from inception cohort registry study of patients with crohn’s disease (iCREST-CD). J Crohn’s Colitis. 2023;17(8):1193–206.
Mak WY, Mak OS, Lee CK, Tang W, Leung WK, Wong MTL, Sze ASF, Li M, Leung CM, Lo FH, et al. Significant medical and surgical morbidity in perianal crohn’s disease: results from a Territory-Wide study. J Crohn’s Colitis. 2018;12(12):1392–8.
Zhu P, Chen Y, Gu Y, Chen H, An X, Cheng Y, Gao Y, Yang B. Analysis of clinical characteristics of perianal Crohn’s disease in a single-center. Zhonghua Wei Chang Wai Ke Za zhi = Chin J Gastrointest Surg. 2016;19(12):1384–8.
Kaur M, Panikkath D, Yan X, Liu Z, Berel D, Li D, Vasiliauskas EA, Ippoliti A, Dubinsky M, Shih DQ, et al. Perianal crohn’s disease is associated with distal colonic disease, stricturing disease behavior, IBD-associated serologies and genetic variation in the JAK-STAT pathway. Inflamm Bowel Dis. 2016;22(4):862–9.
Nasir BF, Griffiths L, Nasir A, Roberts R, Barclay M, Gearry R, Lea RA. Perianal disease combined with NOD2 genotype predicts need for IBD-related surgery in crohn’s disease patients from a population-based cohort. J Clin Gastroenterol. 2013;47(3):242–5.
Google Scholar
Weersma RK, Stokkers PC, van Bodegraven AA, van Hogezand RA, Verspaget HW, de Jong DJ, van der Woude CJ, Oldenburg B, Linskens RK, Festen EA, et al. Molecular prediction of disease risk and severity in a large Dutch crohn’s disease cohort. Gut. 2009;58(3):388–95.
Google Scholar